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The ligand-activated transcription factor AhR mediates the cutaneous stress 
response toward a variety of environmental noxae and is therefore currently 
of interest for modern preventive medicine. In this issue, Tsuji et al. identify 
the antifungal agent ketoconazole as an inducer of AhR signaling and the Nrf2 
antioxidant response in human keratinocytes. Ketoconazole-stimulated nucle-
ar translocation of Nrf2 and its cytoprotective effects against oxidative stress 
strongly depend on a functional AhR. This newly identified AhR–Nrf2 pathway 
opens up new opportunities to prevent and treat inflammatory skin diseases.
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ahr and nrf2 are key regulators  
of drug metabolism
The AhR, a ligand-dependent transcrip-
tion factor, is an important regulator 
of drug metabolism that is activated by 
a broad spectrum of low-molecular-
weight compounds, including diox-
ins, polycyclic aromatic hydrocarbons, 
plant polyphenols, and tryptophan 
photoproducts (Abel and Haarmann-
Stemmann, 2010; Rannug and Fritsche, 
2006). In the absence of a ligand, the 
AhR is trapped in a cytosolic multipro-
tein complex consisting of heat shock 
protein 90, tyrosine kinase c-src, and 
other cochaperones. Upon ligand bind-
ing, this complex dissociates and the 
AhR shuttles into the nucleus, dimer-
izes with ARNT, and binds to so-called 
xenobiotic-responsive elements in the 
promoter region of genes to stimulate 
their expression. Prototype AhR target 
genes encode for the phase I enzymes 
cytochrome P450 (CYP) 1A1, CYP1A2, 
and CYP1B1. These mono oxygenases 
introduce functional groups into lipo-
philic chemicals to enhance their water 
solubility. The resulting metab olites 
are then conjugated to hydrophilic 
molecules, including activated sulfate, 
glutathione, and glucuronic acid. The 
expression of several enzymes respon-
sible for these phase II reactions, such 
as various glutathione S-transferases and 
UDP-glucuronosyltransferases, are also 
regulated in an AhR–ARNT-dependent 
manner.
In addition, many of these 
phase II enzymes are transcriptionally 
coregulated by antioxidant-responsive 
elements (AREs) located adjacent to 
the xenobiotic-responsive elements 
(Haarmann-Stemmann and Abel, in 
press). These AREs are recognized by 
the transcription factor Nrf2, the master 
regulator of the cellular anti oxidant 
response. In the cytoplasm Nrf2 is bound 
to kelch-like ECH-associated protein 1 
(Keap1), which prohibits Nrf2 nuclear 
translocation and thus facil itates con-
stant proteasomal degradation. Upon 
oxidative stress, dissociation of Nrf2 
from Keap1 permits Nrf2 shuttling into 
the nucleus, where it binds to small Maf 
proteins to form a transcriptionally active 
complex to induce ARE-dependent 
responses (Haarmann-Stemmann and 
Abel, in press). Because exposure to 
AhR ligands such as dioxins, polycyclic 
aromatic hydrocarbons, and flavonoids 
results in the CYP-mediated formation 
of reactive oxygen species (ROS) and 
electrophilic metabolites, the interaction 
between AhR and Nrf2 signaling is prob-
ably a crucial enhancer of cyto protection 
against toxic by-products of the AhR-
dependent detoxification process.
new insight into the molecular 
mechanisms of ahr–nrf2 cross-talk
Although earlier studies revealed that 
expression of Nrf2 can be modulated via 
the ligand-activated AhR, and vice versa 
(Miao et al., 2005; Shin et al., 2007), 
the work by Tsuji et al. (2012, this issue) 
considerably expands our view on the 
cross-talk between these intra cellular 
sensor molecules. The investigators used 
normal human epidermal keratinocytes 
treated with ketoconazole (KCZ), a 
widely used imidazole antifungal agent 
that exhibits anti-inflammatory proper-
ties in addition to its therapeutic effects 
against Malassezia spp. and related skin 
pathogens. KCZ exposure stimulated 
nuclear translocation of the AhR, lead-
ing to enhanced expression of CYP1A1, 
an observation in line with previously 
reported AhR-activating properties of 
KCZ in human HepG2 hepatoma cells 
(Korashy et al., 2007).
More interesting is the observa-
tion that KCZ treatment resulted in a 
nuclear translocation of Nrf2 without 
intracellular ROS production. Using 
transient RNA interference, the inves-
tigators further demonstrated that the 
KCZ-induced nuclear translocation 
of Nrf2 strongly depends on a func-
tional AhR cascade, as illustrated in 
Figure 1. Surprisingly, the “classic” 
AhR ligand benzo(a)pyrene (BaP) was 
not capable of inducing Nrf2 nuclear 
translocation, pointing to a ligand-
specific phenomenon. As mentioned 
above, the Nrf2 gene locus contains 
functional binding sites for AhR–ARNT, 
which would explain an upregulation 
of Nrf2 expression but not an activation 
of processed Nrf2 protein. Therefore, 
another molecular link may contribute 
to the AhR-dependent nuclear accumu-
lation of Nrf2.
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Besides disturbance of the Nrf2–
Keap1 complex through interaction of 
its cysteine residues with electrophiles, 
an important step in the dissociation 
of Nrf2–Keap1 is phosphorylation 
of the Nrf2 protein in the cytoplasm. 
This stabilization step is mediated 
by several kinases, including protein 
kinase C, phosphatidylinositol-3-ki-
nase, and mitogen-activated protein 
kinases (MAPKs). Interestingly, ligand-
dependent activation of the AhR is 
accompanied by stimulation of protein 
kinase C and activation of MAPK signal-
ing (Haarmann-Stemmann et al., 2009).
We have previously identified the 
AhR as a crucial mediator of the UVB 
stress response in human keratinocytes, 
which triggers activation of the epi-
dermal growth factor receptor (EGFR) 
and downstream MAPK cascades upon 
UVB exposure. The initializing event 
for this pathway is the intracellular 
absorption of UVB radiation by trypto-
phan, resulting in the formation of the 
photoproduct 6-formylindolo[3,2-b]
carbazole (FICZ) (Fritsche et al., 2007). 
FICZ is a high-affinity ligand of the AhR 
that stimulates both induction of the 
CYP1A1 response through the classic 
AhR–ARNT pathway and activation 
of the soluble tyrosine kinase c-src. 
c-src is released in the cytoplasm upon 
ligand binding to AhR, and it can inter-
act directly with cell surface receptors, 
such as the EGFR. This in turn activates 
downstream MAPK signaling cascades 
and finally results in the upregulation 
of target genes, e.g., cyclooxygenase-2 
(COX-2) (Fritsche et al., 2007). Hence, 
it is tempting to speculate that KCZ 
activates AhR in keratinocytes, leading 
to the stimulation of MAPK signaling 
via the c-src–EGFR route. The acti-
vated MAPK may then phosphorylate 
Nrf2, a process that may contribute to, 
but not solely explain, KCZ-induced 
Nrf2 nuclear accumulation. Because 
BaP did not influence Nrf2 activation, 
unidentified ligand-specific effects of 
KCZ are probably involved.
ahr-mediated nrf2 activation is 
cytoprotective
Tsuji and colleagues (2012) demon-
strated the functional importance of the 
observed AhR–Nrf2 interaction by intro-
ducing different ROS producers into 
their cell system. Treatment of normal 
human epidermal keratinocytes with 
tumor necrosis factor-α led to intra-
cellular ROS formation and enhanced 
IL-8 production, and both can be abol-
ished by KCZ coexposure. Interestingly, 
the ROS-inhibiting property of KCZ is 
diminished in cells that lack either a 
functional AhR or Nrf2 system. In addi-
tion, KCZ exposure dose-dependently 
reduced BaP-induced ROS production 
and 8-hydroxydeoxyguanosine genera-
tion, as well as IL-8 secretion. Because 
CYP1A1 is the main BaP-metabolizing 
enzyme, one could speculate that the 
reduced production of ROS upon BaP 
exposure observed in the coexposure 
experiments is attributable to the simul-
taneous inhibition of CYP1A1 enzyme 
activity by KCZ. Indeed, it has been 
reported that KCZ, although widely 
used as specific inhibitor of CYP3A4, 
can decrease CYP1A1 enzyme activity 
in human intestinal tissues and human 
HepG2 hepatoma cells (Korashy et al., 
2007; Paine et al., 1999). This would 
also explain the observation that KCZ 
alone did not produce intracellular 
ROS. Because Tsuji et al. (2012) were 
able to reverse the KCZ-mediated inhi-
bition of all three end points by tran-
sient knockdown of Nrf2, the inhibition 
of CYP1A1 alone cannot explain this 
process. An enhanced expression of 
certain Nrf2-dependent BaP-detoxifying 
enzymes (e.g., NAD(P)H:quinone oxi-
doreductase 1) may contribute to the 
reduced toxicity of BaP in KCZ-treated 
keratinocytes. In aggregate, these find-
ings emphasize the relevance of Nrf2 
for the toxicity of BaP and related AhR 
ligands, independent of CYP1A1-
mediated catalysis.
chemoprevention: activation or 
inhibition of ahr?
The findings by Tsuji et al. (2012) 
revealed an anti-inflammatory role 
of AhR in the skin that is attributable 
to the activation of the cytoprotec-
tive Nrf2 system. This is a new and 
unexpected function because we 
have shown that activation of AhR by 
UVB irradiation leads to the induc-
tion of (ROS-producing) CYP1A1 and 
pro-inflammatory COX-2 enzymes 
(Fritsche et al., 2007). On the basis 
of these data, we and others pro-
posed that the UVB-induced activa-
tion of the AhR signaling cascade is 
Figure 1. activation of the ahr–nrf2 pathway by the fungicide ketoconazole (KcZ). KCZ binds to 
the cytosolic AhR, resulting in its nuclear translocation and subsequent dimerization with ARNT. 
The AhR–ARNT complex binds to xenobiotic-responsive elements (XREs) in the promoters of 
target genes (e.g., CYP1A1) and stimulates transcription. Simultaneously, activation of AhR initiates 
dissociation of the Nrf2–kelch-like ECH-associated protein 1 (Keap1) complex via an unknown 
molecular mechanism, but one that probably includes activation of protein kinases. Phosphorylated 
Nrf2 translocates in the nucleus and binds to small Maf proteins. This transcriptionally active complex 
recognizes antioxidant-responsive elements (AREs) in promoter sequences and induces expression of 
target genes, e.g., NAD(P)H:quinone oxidoreductase 1 (NQO1).
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detrimental to skin by contributing to 
photo carcinogenesis and photoaging 
(Agostinis et al., 2007; Tigges et al., 
2011). In line with this concept, it was 
reported that activation of the AhR by 
its prototype ligand 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (TCDD) led to 
enhanced COX-2 expression in rodents 
(Vogel et al., 2000) and increased IL-8 
secretion in U937 macrophages (Vogel 
et al., 2007), again pointing to a pro-
inflammatory function of the AhR. In 
addition, transgenic mice expressing 
a constitutively active form of the AhR 
in keratinocytes develop inflamma-
tory skin lesions that resemble typi-
cal atopic dermatitis (Tauchi et al., 
2005). Finally, most recent studies 
from our group indicate that the AhR 
in keratinocytes serves as a negative 
regulator of nucleotide excision repair, 
again emphasizing that AhR inhibi-
tion may be beneficial for human skin 
(Haarmann-Stemmann et al., 2011).
The apparent discrepancies between 
these reports and the current report by 
Tsuji et al. (2012) may best be recon-
ciled by the existence of ligand-specific 
effects. Indeed, Tsuji et al. observed 
a relatively slight induction of the 
CYP1A1 response upon KCZ treat-
ment, and the affinity of KCZ to the 
AhR ligand-binding domain is prob-
ably not comparable to that of high-
affinity ligands such as TCDD or FICZ. 
We therefore postulate that KCZ is a 
so-called “partial agonist” of the AhR: a 
weak activator of AhR in sole treatment 
but a potent antagonist in coexposure 
with ligands of higher affinity. This phe-
nomenon was previously described 
for several AhR antagonists of plant 
origin, for example, luteolin, curcu-
min, and indigo (Abel and Haarmann-
Stemmann, 2010). Regarding the use 
of such molecules in chemo preventive 
approaches, we recently proposed 
that compounds that both attenuate 
ligand-activated AhR signaling and 
stimulate the Nrf2 system are probably 
the most potent candidates to prevent 
the severe health effects provoked by 
environmental noxae (Haarmann-
Stemmann and Abel, in press). The 
inhibition of activated AhR may reduce 
CYP1-catalyzed metabolic activation 
of chemicals and the Nrf2-initiated 
antioxidant defense may simultane-
ously scavenge the remaining reactive 
metabolites. Whether the antifungal 
agent KCZ is one such promising 
substance has yet to be determined. 
Another interesting task will be to verify 
whether other AhR agonists (such as 
endogenously generated FICZ or food-
contained polyphenols) also activate 
Nrf2 and its downstream enzymes in 
an AhR-dependent manner. It should 
be noted that, in addition to kerati-
nocytes, melanocytes and epidermal 
Langerhans cells express functionally 
active AhR and thus may also be KCZ 
targets (Jux et al., 2009, 2011).
The newly discovered connection of 
the AhR and the Nrf2 pathways directly 
links drug metabolism and cellular 
antioxidant response, thereby open-
ing new opportunities to develop and 
design novel strategies that prevent 
and treat inflammatory skin diseases.
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Clinical Implications
•  The anti-inflammatory property of ketoconazole may be attributable to 
its capability to interfere with AhR and Nrf2 signaling. 
•  The AhR-dependent activation of the Nrf2 pathway opens new 
opportunities in the development of treatment modalities for 
inflammatory skin diseases.
